↓ Skip to main content

Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry

Overview of attention for article published in Prostate Cancer and Prostatic Diseases, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
Published in
Prostate Cancer and Prostatic Diseases, January 2019
DOI 10.1038/s41391-018-0121-2
Pubmed ID
Authors

Edoardo Francini, Kathryn P. Gray, Grace K. Shaw, Carolyn P. Evan, Anis A. Hamid, Caitlin E. Perry, Philip W. Kantoff, Mary-Ellen Taplin, Christopher J. Sweeney

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 13%
Researcher 6 13%
Student > Ph. D. Student 4 9%
Student > Doctoral Student 2 4%
Lecturer 2 4%
Other 8 18%
Unknown 17 38%
Readers by discipline Count As %
Medicine and Dentistry 7 16%
Engineering 3 7%
Immunology and Microbiology 3 7%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 9 20%
Unknown 18 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2019.
All research outputs
#3,357,013
of 24,003,070 outputs
Outputs from Prostate Cancer and Prostatic Diseases
#376
of 1,154 outputs
Outputs of similar age
#77,353
of 444,775 outputs
Outputs of similar age from Prostate Cancer and Prostatic Diseases
#11
of 20 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,154 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,775 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.